BibTex RIS Cite

Spinal Anestezi ile Transüretral Rezeksiyon Yapılan Hastalarda Bupivakain ve Ropivakaine Bağlı Geçici Nörolojik Semptom İnsidansının Karşılaştırılması

Year 2009, Volume: 42 Issue: 2, 61 - 68, 01.08.2009

Abstract

İn the present study ıve compared transient neurological symptoms, and recovery characteristics of patients undergoing transurethral resection in lithotomy position with spinal anesthesia using bupivacaine or ropivacaine. Ninety ASA 1-3 patients were enrolled in to the study. Spinal anesthesia was performed with modified pencil-point needle in sitting position in ali patients. Group 1; received 3 mL of 0.5% hyperbaric bupivacaine 15 mg, group 2; 3 mL of 0.5% hyperbaric ropivacaine 15 mg and group 3; 3 mL of isobaric ropivacaine 15 mg. Hemodynamic parameters, level of sensorial and motor block were recorded. At 24, 48 and 72 hand one week later, patients were interviewed about pain in surgical area, lumbar pain and transient neurological symptoms. The regression time of sensorial block to L1 dermatome was longer in hyperbaric bupivacaine group. The complete resolution of motor was shortest in hyperbaric ropivacaine group and iongest in hyperbaric bupivacaine group. There was no dif-ference among the group regarding surgical and lumbar pain, and transient neurological symptom. One patient both in hyper-baric bupivacaine and hyperbaric ropivacaine group had transient neurological symptom. The lumbar pain was moderate in both patients and symptoms resoived completely in ten days. İn conclusion, similar sensorial and motor block levels were obtained with bupivacaine and ropivacaine. The duration of sensorial and motor block were shorter in both ropivacaine groups. The inci-dence of transient neurological symptoms were similar in three groups. Ropivacaine can be an alternative to bupivacaine in short duration surgical procedures with its similar effects and transient neurological symptoms incidence.

References

  • Freedman JM, Li DK, Drasner K, et al. Transierıt rıeurolojic symptoms after spinal anesthesia. Anesthesiology 1998;89:633-41.
  • Ben-David B, Maryanovsky M, Gurevitch A, et al. A compa- rison of minidose lidocaine-fentanyl and conventional-dose lidocaine spinal anesthesia. Anesth Analg 2000;91:865-70.
  • Yamashita A, Matsumoto M, Matsumoto S, et al. /4 compari- son of the neurotoxic effects on the spinal cord of tetracai- ne, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits. Anesth Analg 2003;97:512-9.
  • Corbey MP, Bach AB. Transient radicular irritation (TRI) after spinal anaesthesia in day-care surgery. Açta Anaesthesiol Scand 1998;42:425-9.
  • Hampi KF, Heinzmann-VVİedmer S, Luginbuehl I, et al. Transient neurologic symptoms after spinal anesthesia. Anesthesiology 1998;88:629-33.
  • Keld DB, Hein L, Dalgaard M, et al. The incidence of transi­ ent neurologic symptoms (TNS) after spinal anaesthesia in patients undergoing surgery in the supin position. Hyperbaric lidocaine 5% versus hyperbaric bupivacaine 0.5% Açta Anaesthesiol Scand 2000;44:285-90.
  • Zaric D, Christiansen C, Pace NL, Punjasawadwong Y. Transient neurologic symptoms (TNS) follovving spinal ana­ esthesia with lidocaine versus other local anaesthetics. Cochrane Database Syst Rev 2005;19:CD003006.
  • Levin A, Datta S, Camann WR. Intrathecal ropivacaine for labor analgesia: A comparison with bupivacaine. Anesth Analg 1998;87:624-7.
  • Kristensen JD, Karlsten R, Gordh T. Spinal cord blood flow after intrathecal injection of ropivacaine: A screening for neurotoxic effects. Anesth Analg 1996;82:636-40.
  • KhawKS, Kee N, Wong Y, et al. Spinal ropivacaine forcesa- rean section. Anesthesiology 2001;95:1346-50.
  • Gautier PE, De Kock M, Van Steenberge AV, et al. Intrathecal ropivacaine for ambuiatory surgery. A comparison between intrathecal bupivacaine and intrathecal ropivacaine for knee arthroscopy. Anesthesiology 1999;91:1239-45.
  • Ganapathy, Sugantha FR, Sandhu, et al. Transient neurolo­ gic symptom (TNS) follovving intrathecal ropivacaine. Anesthesiology 2000;93:1537-40.
  • Carpenter RL. (letter) Hyperbaric lidocaine spinal anesthesia: Do we need an alternative? Anesth Analg 1995; 81:1125-8.
  • Hodgson PS, Neal JM, Pollock JE, et al. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg 1999;88: 797-809.
  • Hampi KF, Schneider MC, Pargger H, et al. A sim Har inci­ dence of transient neurologic symptoms after spinal anest­ hesia with 2% and 5% lidocaine. Anesth Analg 1996; 83:1051-4.
  • Pollock JE, Mulroy MF, Stephenson CA. Spinal anesthetics and the incidence of transient radicualar irritation. Anesthesiology 1994;81:A1029.
  • Sakura S, Chan VW, Ciriales R, et al. The addition of 7.5% glucose does not alter the neurotoxicity of 5% lidocaine administered intrathecally in the rat. Anesthesiology 1995; 82:236-40.
  • Hashimoto K, Sakura S, Bollen AW, Ciriales R, Drasner K. Comparative toxicity of glucose and lidocaine administered intrathecally in the rat. Reg Anesth Pain Med 1998;23:444-50.
  • Casati A, Moizo E, Marchetti C, Vinciguerra F. A prospecti- ve, randomized, double-blind comparison of unilateral spi­ nal anesthesia with hyperbaric bupivacaine, ropivacaine, or levobupivacaine for inguinal herniorrhaphy. Anesth Analg 2004;99:1387-92.
  • McDonald SB, Liu SS, Kopacz DJ, Stephenson CA. Hyperbaric spinal ropivacaine: A comparison to bupivacaine in volunteers. Anesthesiology 1999;90:971-7.
  • Brattebo G, Wisborg T, RodtSA, et al. Is the pencil point spi­ nal needie a better choice in younger patients? A compari­ son of 24G Sprotte with 27G Ouincke needles in an unse- tected group of general surgical patients below 46 years of age. Açta Anaesthesiol Scand 1995;39:535-8.
  • Wahedi W, Nolte H, Klein P. Ropivacaine for spinal anaest­ hesia: A dose finding study. Br J Anaesth 1994;72:164-9.
  • Malinovsky JM, Charles F, Kick O, et al. Intrathecal anest­ hesia: Ropivacaine versus bupivacaine. Anesth Analg 2000;91:1457-60.

The Comparison of the Incidence of Transierıt Neurological Symptoms Associated By Bupivacain and Ropivacain in Patients Undergoing Transurethral Resection with Spinal Anesthseia

Year 2009, Volume: 42 Issue: 2, 61 - 68, 01.08.2009

Abstract

Bu çalışmada spinal anestezi ile litotomi pozisyonunda transüretral rezeksiyon uygulanan hastalarda, bupivakain ve ropivakaine bağlı geçici nörolojik semptom insidansı ve derlenme özellikleri karşılaştırıldı. ASA 1 -3 grubundan 90 hasta çalışmaya alındı. Spinal anestezi tüm hastalarda oturur pozisyonda, modifiye "pencil-point" iğne kullanılarak uygulandı. Birinci gruba 3 mL 15 mg %0.5 hiperbarik bupivakain, ikinci gruba 3 mL 15 mg %0.5 hiperbarik ropivakain, üçüncü gruba ise 3 mL 15 mg izobarik ropi-vakain enjekte edildi. Hemodinamik parametreler ile sensöriyel ve motor blok düzeyleri kaydedildi. Hastalarla 24, 48 ve 72. saatlerde ve bir hafta sonunda görüşülerek operasyon bölgesinde ağrı, bel ağrısı ve geçici nörolojik semptomlar sorgulandı. Sensöriyel bloğun L1 dermatomuna gerileme süresi hiperbarik bupivakain grubunda, ropivakain gruplarına göre anlamlı olarak uzun bulundu. Motor bloğun derlenme süresi hiperbarik ropivakain grubunda en kısa, hiperbarik bupivakain grubunda ise en uzundu. Gruplar arasında operasyon bölgesindeki ağrı ve bel ağrısı ile geçici nörolojik semptom insidansı yönünden anlamlı farklılık bulunmadı. Hiperbarik bupivakain ve hiperbarik ropivakain gruplarında birer hastada geçici nörolojik semptom bulguları görüldü. Her iki hastada bel ağrısı orta şiddetliydi ve semptomlar 10. günde tamamen düzeldi. Sonuç olarak, transüretral rezeksiyon operasyonlarında, bupivakain ve ropivakain ile benzer sensöriyel ve motor blok düzeyi elde edildi. Ancak sensöriyel ve motor blok süresi ropivakain gruplarında bupivakaine göre daha kısaydı. Geçici nörolojik semptom insidansı her üç grupta benzerdi. Benzer etki profili ve geçici nörolojik semptom insidansı ile ropivakain, kısa süreli cerrahi girişimlerde bupivakaine alternatif olabilecek bir anestezik ajandır.

References

  • Freedman JM, Li DK, Drasner K, et al. Transierıt rıeurolojic symptoms after spinal anesthesia. Anesthesiology 1998;89:633-41.
  • Ben-David B, Maryanovsky M, Gurevitch A, et al. A compa- rison of minidose lidocaine-fentanyl and conventional-dose lidocaine spinal anesthesia. Anesth Analg 2000;91:865-70.
  • Yamashita A, Matsumoto M, Matsumoto S, et al. /4 compari- son of the neurotoxic effects on the spinal cord of tetracai- ne, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits. Anesth Analg 2003;97:512-9.
  • Corbey MP, Bach AB. Transient radicular irritation (TRI) after spinal anaesthesia in day-care surgery. Açta Anaesthesiol Scand 1998;42:425-9.
  • Hampi KF, Heinzmann-VVİedmer S, Luginbuehl I, et al. Transient neurologic symptoms after spinal anesthesia. Anesthesiology 1998;88:629-33.
  • Keld DB, Hein L, Dalgaard M, et al. The incidence of transi­ ent neurologic symptoms (TNS) after spinal anaesthesia in patients undergoing surgery in the supin position. Hyperbaric lidocaine 5% versus hyperbaric bupivacaine 0.5% Açta Anaesthesiol Scand 2000;44:285-90.
  • Zaric D, Christiansen C, Pace NL, Punjasawadwong Y. Transient neurologic symptoms (TNS) follovving spinal ana­ esthesia with lidocaine versus other local anaesthetics. Cochrane Database Syst Rev 2005;19:CD003006.
  • Levin A, Datta S, Camann WR. Intrathecal ropivacaine for labor analgesia: A comparison with bupivacaine. Anesth Analg 1998;87:624-7.
  • Kristensen JD, Karlsten R, Gordh T. Spinal cord blood flow after intrathecal injection of ropivacaine: A screening for neurotoxic effects. Anesth Analg 1996;82:636-40.
  • KhawKS, Kee N, Wong Y, et al. Spinal ropivacaine forcesa- rean section. Anesthesiology 2001;95:1346-50.
  • Gautier PE, De Kock M, Van Steenberge AV, et al. Intrathecal ropivacaine for ambuiatory surgery. A comparison between intrathecal bupivacaine and intrathecal ropivacaine for knee arthroscopy. Anesthesiology 1999;91:1239-45.
  • Ganapathy, Sugantha FR, Sandhu, et al. Transient neurolo­ gic symptom (TNS) follovving intrathecal ropivacaine. Anesthesiology 2000;93:1537-40.
  • Carpenter RL. (letter) Hyperbaric lidocaine spinal anesthesia: Do we need an alternative? Anesth Analg 1995; 81:1125-8.
  • Hodgson PS, Neal JM, Pollock JE, et al. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg 1999;88: 797-809.
  • Hampi KF, Schneider MC, Pargger H, et al. A sim Har inci­ dence of transient neurologic symptoms after spinal anest­ hesia with 2% and 5% lidocaine. Anesth Analg 1996; 83:1051-4.
  • Pollock JE, Mulroy MF, Stephenson CA. Spinal anesthetics and the incidence of transient radicualar irritation. Anesthesiology 1994;81:A1029.
  • Sakura S, Chan VW, Ciriales R, et al. The addition of 7.5% glucose does not alter the neurotoxicity of 5% lidocaine administered intrathecally in the rat. Anesthesiology 1995; 82:236-40.
  • Hashimoto K, Sakura S, Bollen AW, Ciriales R, Drasner K. Comparative toxicity of glucose and lidocaine administered intrathecally in the rat. Reg Anesth Pain Med 1998;23:444-50.
  • Casati A, Moizo E, Marchetti C, Vinciguerra F. A prospecti- ve, randomized, double-blind comparison of unilateral spi­ nal anesthesia with hyperbaric bupivacaine, ropivacaine, or levobupivacaine for inguinal herniorrhaphy. Anesth Analg 2004;99:1387-92.
  • McDonald SB, Liu SS, Kopacz DJ, Stephenson CA. Hyperbaric spinal ropivacaine: A comparison to bupivacaine in volunteers. Anesthesiology 1999;90:971-7.
  • Brattebo G, Wisborg T, RodtSA, et al. Is the pencil point spi­ nal needie a better choice in younger patients? A compari­ son of 24G Sprotte with 27G Ouincke needles in an unse- tected group of general surgical patients below 46 years of age. Açta Anaesthesiol Scand 1995;39:535-8.
  • Wahedi W, Nolte H, Klein P. Ropivacaine for spinal anaest­ hesia: A dose finding study. Br J Anaesth 1994;72:164-9.
  • Malinovsky JM, Charles F, Kick O, et al. Intrathecal anest­ hesia: Ropivacaine versus bupivacaine. Anesth Analg 2000;91:1457-60.
There are 23 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Gülbahar Gülnerman This is me

Selma Keleş This is me

Menşure Kaya This is me

Neslihan Kuru This is me

Nihal Kadıoğulları This is me

Publication Date August 1, 2009
Published in Issue Year 2009 Volume: 42 Issue: 2

Cite

APA Gülnerman, G. ., Keleş, S. ., Kaya, M. ., Kuru, N. ., et al. (2009). The Comparison of the Incidence of Transierıt Neurological Symptoms Associated By Bupivacain and Ropivacain in Patients Undergoing Transurethral Resection with Spinal Anesthseia. Acta Oncologica Turcica, 42(2), 61-68.
AMA Gülnerman G, Keleş S, Kaya M, Kuru N, Kadıoğulları N. The Comparison of the Incidence of Transierıt Neurological Symptoms Associated By Bupivacain and Ropivacain in Patients Undergoing Transurethral Resection with Spinal Anesthseia. Acta Oncologica Turcica. August 2009;42(2):61-68.
Chicago Gülnerman, Gülbahar, Selma Keleş, Menşure Kaya, Neslihan Kuru, and Nihal Kadıoğulları. “The Comparison of the Incidence of Transierıt Neurological Symptoms Associated By Bupivacain and Ropivacain in Patients Undergoing Transurethral Resection With Spinal Anesthseia”. Acta Oncologica Turcica 42, no. 2 (August 2009): 61-68.
EndNote Gülnerman G, Keleş S, Kaya M, Kuru N, Kadıoğulları N (August 1, 2009) The Comparison of the Incidence of Transierıt Neurological Symptoms Associated By Bupivacain and Ropivacain in Patients Undergoing Transurethral Resection with Spinal Anesthseia. Acta Oncologica Turcica 42 2 61–68.
IEEE G. . Gülnerman, S. . Keleş, M. . Kaya, N. . Kuru, and N. . Kadıoğulları, “The Comparison of the Incidence of Transierıt Neurological Symptoms Associated By Bupivacain and Ropivacain in Patients Undergoing Transurethral Resection with Spinal Anesthseia”, Acta Oncologica Turcica, vol. 42, no. 2, pp. 61–68, 2009.
ISNAD Gülnerman, Gülbahar et al. “The Comparison of the Incidence of Transierıt Neurological Symptoms Associated By Bupivacain and Ropivacain in Patients Undergoing Transurethral Resection With Spinal Anesthseia”. Acta Oncologica Turcica 42/2 (August 2009), 61-68.
JAMA Gülnerman G, Keleş S, Kaya M, Kuru N, Kadıoğulları N. The Comparison of the Incidence of Transierıt Neurological Symptoms Associated By Bupivacain and Ropivacain in Patients Undergoing Transurethral Resection with Spinal Anesthseia. Acta Oncologica Turcica. 2009;42:61–68.
MLA Gülnerman, Gülbahar et al. “The Comparison of the Incidence of Transierıt Neurological Symptoms Associated By Bupivacain and Ropivacain in Patients Undergoing Transurethral Resection With Spinal Anesthseia”. Acta Oncologica Turcica, vol. 42, no. 2, 2009, pp. 61-68.
Vancouver Gülnerman G, Keleş S, Kaya M, Kuru N, Kadıoğulları N. The Comparison of the Incidence of Transierıt Neurological Symptoms Associated By Bupivacain and Ropivacain in Patients Undergoing Transurethral Resection with Spinal Anesthseia. Acta Oncologica Turcica. 2009;42(2):61-8.